Loading…
H.R. 7479119th CongressIn committeeLatest action Feb 10, 2026Decoded by AI · checked against the record
The plain-language version leads. The official text is always the reference.
HR 7479 mandates naloxone at all federal agencies and offers voluntary guidance to private employers on stocking the medication.
50-second read · 4 questions answered below
HR 7479 directs OSHA to publish voluntary guidance for private employers on stocking and maintaining opioid overdose reversal medication, such as naloxone, and to encourage optional annual worker training. Separately, the bill legally requires every federal agency to keep overdose reversal medication on hand and to offer voluntary annual training to employees. Both actions must occur within 270 days of the bill becoming law.
Federal government workers across all agencies, including the Veterans Health Administration, would be directly covered by the mandatory requirement. Private-sector employers and their workers face no new legal obligations, though official guidance would be available to them; the United States Postal Service is specifically excluded from the private-employer guidance section.
Opioid overdoses remain a leading cause of accidental death in the United States, and the bill is aimed at improving workplace preparedness to respond to them. Federal workplaces would see a guaranteed change in available resources, while the effect on private workplaces would depend entirely on voluntary employer decisions.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Referred to the House Committee on Education and Workforce.